Literature DB >> 25338181

The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck.

Małgorzata Wierzbicka1, Anna Bartochowska1, Vratislav Strnad2, Primož Strojan3, William M Mendenhall4, Louis B Harrison5, Alessandra Rinaldo6, Puja Sahai7, Susanne Wiegand8, Alfio Ferlito9.   

Abstract

Brachytherapy is a form of intensive local irradiation, allowing effective protection of surrounding structures with preservation of organ function and results in a favorable therapeutic ratio. It can be used alone, adjuvantly after surgery, and as a local boost in combination with external-beam radiation therapy. This paper is a literature review on the role of brachytherapy in the management of head and neck cancers with a special emphasis on papers published in the last 5 years. Technical details, effectiveness and potential toxicities of brachytherapy when used in different combinations with other therapeutic modalities and tumor sites are presented. Brachytherapy is an attractive treatment option in the management of primary malignancies and recurrent tumors in previously irradiated areas of the head and neck. It is effective and safe, and results in good functional and oncological outcomes.

Entities:  

Keywords:  Brachytherapy; HDR; Head and neck cancers; PDR; Squamous cell carcinoma

Mesh:

Year:  2014        PMID: 25338181     DOI: 10.1007/s00405-014-3332-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  41 in total

1.  From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.

Authors:  Jose-Luis Guinot; Leoncio Arribas; Maria Isabel Tortajada; Vicente Crispín; Maria Carrascosa; Miguel Santos; Alejandro Mut; Juan Bosco Vendrell; Carmen Pesudo; Maria Luisa Chust
Journal:  Brachytherapy       Date:  2013-07-11       Impact factor: 2.362

2.  A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.

Authors:  M Umeda; H Komatsubara; Y Ojima; T Minamikawa; Y Shibuya; S Yokoo; J Ishii; T Komori
Journal:  Int J Oral Maxillofac Surg       Date:  2005-10       Impact factor: 2.789

3.  Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy.

Authors:  Rafael Martínez-Monge; Mauricio Cambeiro; Marta Moreno; Miren Gaztañaga; Mikel San Julián; Juan Alcalde; Matías Jurado
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-15       Impact factor: 7.038

4.  Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer.

Authors:  Keiji Matsumoto; Tomonari Sasaki; Yoshiyuki Shioyama; Katsumasa Nakamura; Kazushige Atsumi; Takeshi Nonoshita; Saiji Ooga; Tadamasa Yoshitake; Satoru Uehara; Hideki Hirata; Hiroshi Honda
Journal:  Jpn J Clin Oncol       Date:  2013-08-01       Impact factor: 3.019

5.  Perioperative image-adapted brachytherapy for the treatment of paranasal sinus and nasal cavity malignancies.

Authors:  Ingo U Teudt; Jens E Meyer; Matthias Ritter; Barbara Wollenberg; Torsten Kolb; Steffen Maune; György Kovàcs
Journal:  Brachytherapy       Date:  2013-11-07       Impact factor: 2.362

6.  Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.

Authors:  Vratislav Strnad; Michael Lotter; Stephan Kreppner; Rainer Fietkau
Journal:  Brachytherapy       Date:  2013-11-06       Impact factor: 2.362

7.  Longitudinal changes in quality of life and costs in long-term survivors of tumors of the oropharynx treated with brachytherapy or surgery.

Authors:  Wideke M Nijdam; Peter C Levendag; Inge Noever; Paul I M Schmitz; Carin A Uyl-de Groot
Journal:  Brachytherapy       Date:  2008-09-10       Impact factor: 2.362

8.  Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer.

Authors:  Ly Do; Ajmel Puthawala; Nisar Syed
Journal:  Brachytherapy       Date:  2009-09-03       Impact factor: 2.362

9.  The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.

Authors:  Vratislav Strnad; Matthias Geiger; Michael Lotter; Rolf Sauer
Journal:  Brachytherapy       Date:  2003       Impact factor: 2.362

Review 10.  High dose rate brachytherapy for oral cancer.

Authors:  Hideya Yamazaki; Ken Yoshida; Yasuo Yoshioka; Kimishige Shimizutani; Souhei Furukawa; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-11-23       Impact factor: 2.724

View more
  2 in total

1.  Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases.

Authors:  Ingo U Teudt; György Kovàcs; Matthias Ritter; Corinna Melchert; Tamer Soror; Barbara Wollenberg; Jens E Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-23       Impact factor: 2.503

2.  Single Fraction Stereotactic Radiosurgery for Retreatment of Skull Base Recurrent Head and Neck Malignancies.

Authors:  Rajal A Patel; Derrick Lock; Thomas Kim; Sandeep Samant; James P Chandler; Bharat B Mittal; Tim J Kruser
Journal:  Cureus       Date:  2017-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.